Home > Healthcare & Medical Devices > Cranial Stabilization Devices Market
Cranial Stabilization Devices Market Size is expected to witness momentous growth from 2022 to 2028 owing to the growing count of head surgeries and the shifting inclination towards minimally invasive neurosurgeries. The higher prevalence of pediatric abnormalities and spinal trauma has resulted in the increasing preference for effective reconstructive surgeries.
Cranial stabilization devices are employed by healthcare practitioners to ensure rigid fixation whilst holding the patients head and neck in surgical procedures.
The rising adoption of high-end stabilization devices and the significant strides in healthcare infrastructure will additionally spur the market progression. However, the improper implementation of clinical practice guidelines, the dearth of expertise along the lack of proper healthcare infrastructure in emerging countries may negatively influence the product demand.
With respect to products, the brain retractor systems will increase with the rising need for lesser injuries as well as enhanced handling systems and stability in neurosurgeries. The growing focus on high-quality visualization of tissues will also add to the market growth. The skull clamp system segment is estimated to foresee significant growth through 2028 with the increasing requirement for firmly holding a patient's head to the operating table in instances of craniotomy drilling and delicate surgeries. Rising popularity as a most utilized neurosurgical instrument across the world is an ideal factor driving the segment expansion.
Based on end-use, the cranial stabilization devices market is segmented into hospitals, ambulatory surgical centers, specialized centers, and others. The industry revenue from hospitals is set to grow with the increasing preference for surgical procedures in these facilities. The growing number of road accidents worldwide has steered the rise in neurosurgeries. The surging prevalence of tumors and cancer, the higher count of hospital admissions, and the spiraling need for advanced neurosurgery devices are some factors projected to drive the segment value. However, prolonged hospital stays, and the escalating treatment costs may hamper the industry dynamics.
The demand for cranial stabilization devices is anticipated to ramp up in North America, led by the presence of favorable reimbursement policies coupled with the growing prevalence of brain cancer and road accidents. According to the National Brain Tumor Society, over 700,000 people in the U.S. are affected by a primary brain tumor, and more than 85,000 are poised to be diagnosed in 2021. The region is also home to favorable healthcare infrastructure and some leading industry players. The increasing count of surgical centers and hospitals coupled with the thriving need for technologically advanced surgical devices in cranial surgeries will favor the regional expansion.
Well-known participants in the market include OsteoMed (Marmon Group), Jintan Huida Medical Instrument Co. Ltd., DePuy Synthes (Johnson & Johnson), Micromar, ZheJiang Apeloa JiaYuan Pharmaceutical, Pro med instruments, Integra LifeSciences Holdings Corporation, Medtronic, Changzhou Huida Medical Equipment, Stryker, Zimmer Biomet, and B. Braun Mesulgen AG.
Strategic marketing ventures, including acquisitions, partnerships, along with new product launches and approvals are actively adopted by these companies to reinforce their market position and to sustain the growing competition.
For instance, in July 2021, Integra LifeSciences Holdings Corporation was granted the FDA clearance for a specific indication for neurosurgery for CUSA®, its clarity ultrasonic surgical aspirator system.
In another instance, Medtronic plc, in December 2019, announced the U.S. FDA (Food and Drug Administration) approval for its cranial robotic platform, Stealth Autoguide™ system, integrated with its enabling technology portfolio for creating an end-to-end procedural solution.
The COVID-19 outbreak and its subsequent disruptions brought significant effects on various end-use sectors given the regulation of nationwide lockdowns and trade restrictions. Its impact was also considerably felt on the market demand for cranial stabilization devices owing to the rising number of hospital admissions to treat the infection, adversely affecting the neurosurgical procedures. The higher threat of contracting the virus from the surgeons and staff performing the surgeries also posed a barrier to the industry progression amid the crisis.
Market, by Product
Market, by End-use
The above information is provided for the following regions and countries: